Search

Start Over Keyword ISONIAZID PREVENTIVE THERAPY

  • Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model

    Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model
    Authors:Riti Sharan, Texas Biomedical Research InstituteShashank Ganatra, Texas Biomedical Research InstituteAllison N Bucsan, Washington UniversityJourney Cole, Texas Biomedical Research InstituteDhiraj K Singh, Texas Biomedical Research InstituteXavier Alvarez, Texas Biomedical Research InstituteMaya Gough, Texas Biomedical Research InstituteCynthia Alvarez, Texas Biomedical Research InstituteAlyssa Blakley, Texas Biomedical Research InstituteJustin Ferdin, Texas Biomedical Research InstituteRajesh Thippeshappa, Texas Biomedical Research InstituteBindu Singh, Texas Biomedical Research InstituteRuby Escobedo, Texas Biomedical Research InstituteVinay Shivanna, Texas Biomedical Research InstituteEdward J Dick, Texas Biomedical Research InstituteShannan Hall-Ursone, Texas Biomedical Research InstituteShabaana A Khader, Washington UniversitySmriti Mehra, Texas Biomedical Research InstituteJyothi Rengarajan, Emory UniversityDeepak Kaushal, Texas Biomedical Research Institute
    Date:2022
    Publisher:AMER SOC CLINICAL INVESTIGATION INC
    Publication Version:Final Published Version
    License:Creative Commons Attribution 4.0 International

  • What We Know About Tuberculosis Transmission: An Overview

    What We Know About Tuberculosis Transmission: An Overview
    Authors:Gavin Churchyard, Aurum InstitutePeter Kim, National Institutes of HealthNippie Shah, Emory UniversityRoxana Rustomjee, National Institutes of HealthNeel R. Gandhi, Emory UniversityBarun Mathema, Columbia UniversityDavid Dowdy, Johns Hopkins UniversityAnne Kasmar, Bill and Melinda Gates FoundationVicky Cardenas, Aurum Institute
    Date:2017
    Publisher:Oxford University Press (OUP): Policy B - Oxford Open Option C
    Publication Version:Final Published Version
    License:Creative Commons Attribution 3.0 IGO License

  • Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?

    Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?
    Authors:Sara Auld, Emory UniversityAnne G Kasmar, Bill and Melinda Gates FoundationDavid W Dowdy, Johns Hopkins UniversityBarun Mathema, Columbia UniversityNeel Gandhi, Emory UniversityGavin J Churchyard, University of WitwatersrandRoxana Rustomjee, National Institute of Allergy and Infectious DiseasesNippie Shah, Emory University
    Date:2017
    Publisher:Oxford University Press (OUP): Policy B - Oxford Open Option C
    Publication Version:Final Published Version
    License:Creative Commons Attribution 3.0 IGO License

  • Tuberculosis Infectiousness and Host Susceptibility

    Tuberculosis Infectiousness and Host Susceptibility
    Authors:Richard D Turner, Kings College Hospital LondonChristopher Chiu, Imperial College LondonGavin J Churchyard, Aurum InstituteHanif Esmail, University of OxfordDavid M Lewinsohn, Oregon Health & Science UniversityNeel Gandhi, Emory UniversityKevin P Fennelly, National Heart, Lung, and Blood Institute
    Date:2017
    Publisher:Oxford University Press (OUP): Policy B - Oxford Open Option C
    Publication Version:Final Published Version
    License:Creative Commons Attribution 3.0 IGO License